September 23, 2009 2:51 PM
- Text
Pfizer's Lawyers Play Musical Chairs in Wake of Bextra Settlement
(MoneyWatch) Pfizer's lawyers have found themselves playing musical chairs since the $2.3 billion Bextra settlement. The general counsel's office has been stripped of part of its compliance role under a new corporate integrity agreement with the government (stemming from the Bextra scandal). More recently, senior corporate counsel Paulette Morgan left Pfizer to join Nixon Peabody as counsel. Law.com:
Nixon Peabody spokesman Brian Moynihan said Morgan's move from Pfizer is unrelated to the government's charges against the company and the subsequent settlement.The post-Bextra compliance arrangement with the government means less work for the general counsel's office because it loses a compliance role. Legal Week:
Instead, the chief compliance officer at the world's largest drug maker will report directly to the chief executive. The move is required by Pfizer's corporate integrity agreement with the office of the inspector general of the US Department of Health and Human Services (HHS), part of the company's civil and criminal settlement with the Department of Justice.
The change is intended to eliminate conflicts of interest, and prevent Pfizer's in-house lawyers from reviewing or editing reports required by the agreement, said Lewis Morris, chief counsel for the inspector general's office. Officials at Pfizer did not respond to requests for comment.
"The lawyers tell you whether you can do something, and compliance tells you whether you should," Morris added. "We think upper management should hear both arguments."Of course, it's not a complete sidestep of Pfizer's lawyers. CEO Jeffrey Kindler was, after all, general counsel to Pfizer before he became its chief.
- Previously:
- Pfizer Used Docs Accused of Misconduct to Prep Geodon Submission to FDA
- Pfizer Paid for Doc's Helicopter in Off-Label Geodon Push, Suit Claims
- Pfizer Turned NAMI Into "Trojan Horse" to Push Geodon Off-Label to Kids, Suit Claims
- "Pfizer Math" Showed Lyrica Superiority Even Though Studies Never Said That, Rep Claims
- Pfizer Rep Claims Bextra Pushed on NHL's Blue Jackets
- Pfizer Rep Claims Zoloft Touted for Failed Cheerleaders; Viagra for Women
- Pfizer Rep Alleges Viagra Promoted With Unapproved Materials: "Get Those Things Cleaned Up!"
- Pfizer Stock Shrugs Off $2.3B Bextra Fine; Can Anything Deter Off-Label Promotion?
- Pfizer Rep Describes Pushing Zyvox With Flawed Data
- Pfizer's West Side Story: How "the Sharks" Sold Bextra Off-Label
- 10 Amazing Facts About Pfizer's $2.3B Bextra Settlement
Latest Now in MoneyWatch
- Ohio unemployment hits 3-year-low
- Jill on Money: Retirement investing, allocation, long term care
- Could "web-lining" be dangerous?
- Insurers respond cautiously to contraceptive plan
- Judge: Legally, breastfeeding not related to pregnancy
- Budget deficit drops to $27 billion in January
- Why the Powerball Jackpot is part of my investment strategy
- Is the new VW Beetle diesel worth the money?
- Consumer sentiment highlights risks to recovery
- Valentine blues? 10 best cities to be single
- December trade deficit widens to $48.8 billion
- Alcatel-Lucent returns to profit in 2011
- 6 things never to say in a performance review
- $26B mortgage deal: Who gets the money?
- Friendly's CEO steps down
- Quarterly loss hits $3.3B at Postal Service
- Greeks rail against cuts as EU demands more
Latest CBS News Headlines
on Facebook
on CBS News
- Richardson hits nine 3s, Magic top Bucks 99-94
- Smith stops 38 shots, Coyotes top Blackhawks 3-0
- Whitney Houston's voice will never be forgotten
- Reactions to Whitney Houston's death
on Facebook
- Adele sings a cappella for Anderson Cooper
- Occupy protestors kicked out of CPAC
- CPAC: Will Sarah Palin spring a surprise?
- Beyonce and Jay-Z post first photos of Blue Ivy Carter
on CBS News






